SOT is a personalised therapy for cancer, viruses and pathogens including Lyme Disease. The SOT has the ability to bind to a specific gene of interest that controls the cancer cell or pathogen by disrupting the critical process that promotes its survival or growth. During this therapy, we analyse a patient’s blood and we create a complementary oligonucleotide sequence that is designed to interrupt survival or growth of the cells. RGCC SOTs are available to RGCC Network doctors. Please contact us to discuss your requirements.